Pharma Logistics IQ sat down with Paul O'Connor, Global Vice President Quality, Almac who are a sponsor of the Clinical Trial Supply Forum 2019, to talk about the potential effects of Brexit on the industry and how ALMAC is preparing for these changes.
Ahead of the Clinical Trial Supply Forum 2019, experts from all regions and areas within clinical trial supply participated in our survey, to give us insight on the main logistical challenges that exist in global clinical trials. This survey looks at the main challenges and drivers facing companies in 2019 and looks ahead to what this means for the future. It also looks at how things have changed over the last year.
Interested in finding out more about this event? Download the full agenda here.
Pharma IQ sat down with Buz Hillman, Associate Director, Clinical Supply Systems and Strategy, Janssen and Steven Jacobs Board Chairman, Global Clinical Supplies Group ahead of the Clinical Trial Supply Forum. They discussed in detail topics such as utilising data to drive supply-chain efficiencies and generate the process insights.
In this short trailer you can find out more about what to expect at this year's Clinical Trial Supply Forum. This one-minute video gives a summary of some of the 2019 top speakers, key takeaways you will leave the event with and topics covered.
If you would like more information on this event, including the full list of speakers, sessions, sponsors and event opportunities then please view the full event guide here.
Alternatively, ahead of the forum on the 20 -22 May, we have created three exclusive complimentary pieces of content to give you an insight into the themes and key issues we will be tackling across the 3-event days. To view these please click here.
Join in the conversation or share this at #CTSForum
With 253,834 studies located in 200 countries, ensuring smooth and cost-effective global clinical trial supply has become a standard for the pharmaceutical industry. Experts from all regions have answered our survey on the main pain points they face, how they can improve their supply chain and what drives its success. Anat Batsri, Global Clinical Supply Chain Study Lead at OPKO Biologics, had a look at the results and gave us her feedback on what the results showed.
New labelling requirements: How is the clinical trial supply industry getting ready to stay compliant?
The new Clinical Trials Regulation is to be enforced in 2019 and the clinical trial supply industry is preparing now to remain compliant and companies will have to change their labelling process in order to save costs and stay up to date with the requirements.
In this exclusive article, we have surveyed more than 250 clinical trial supply experts from all around the world to gain insight on where their investment priorities lie in terms of labelling solutions and what their time frame is, in order to better understand how their industry is getting ready to comply with the new legislation.
Improving clinical trial supply through innovative supply chain platforms: Challenges and opportunities
Clinical trials are on the rise and new designs such as adaptive clinical trials are emerging, requiring flexibility and transparency and forcing pharma companies to re-assess their approach to their supply chain to adapt to these changes. Ahead of the Clinical Trial Supply Forum, we sat down with one of the speakers, Antony Pham, Co-founder of consulting and tech-based SPLY ApS to discuss the opportunities and challenges associated with the implementation of new technologies in the supply chain and how they can increase the companies' efficiency while reducing costs.